Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments
Hyperfine, Inc. (HYPR) Q1 2026 Earnings Call Transcript
Hyperfine Q1 Earnings Call Highlights
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates
Hyperfine, Inc. Reports First Quarter 2026 Financial Results
Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference
Hyperfine Swoop® System Introduced as India's First Portable MRI for Bedside Brain Imaging at the Country's Leading Medical Institution
Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026
Forget Neuralink: The Real Brain Tech Trade Has 10 Names You’ve Never Heard
Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software
How Decentralized AI is Unlocking Value in Cardiac Diagnostics
Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine
Hyperfine (NASDAQ:HYPR) and Atossa Genetics (NASDAQ:ATOS) Critical Comparison
Hyperfine, Inc. (HYPR) Q4 2025 Earnings Call Transcript
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Analyzing Hyperfine (NASDAQ:HYPR) and Arrayit (OTCMKTS:ARYC)
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
Short Interest in Hyperfine, Inc. (NASDAQ:HYPR) Increases By 46.4%
Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System's Enhanced Stroke Detection Capabilities
Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics
Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care
Hyperfine, Inc. (NASDAQ:HYPR) Short Interest Update
Hyperfine Announces Regulatory Approval of the Swoop® System in India
Hyperfine (NASDAQ:HYPR) Shares Down 6.8% – Should You Sell?
Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health
Head to Head Review: Hyperfine (NASDAQ:HYPR) vs. Vasamed (OTCMKTS:VSMD)
Hyperfine, Inc. (HYPR) Q3 2025 Earnings Call Transcript
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates
Hyperfine, Inc. Reports Third Quarter 2025 Financial Results
Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting
Hyperfine Announces Pricing of $17.5 Million Public Offering
Hyperfine Announces Proposed Public Offering
Hyperfine Reports Preliminary, Unaudited Results for Third Quarter 2025, Signaling Strong Business Momentum Following the Launch of the Next Generation Swoop® System
Hyperfine Swoop® System Referenced in France's Largest Public Hospital Procurement Body to Facilitate Nationwide Purchases of Portable MRI Technology
Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI
Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
Hyperfine (HYPR) Upgraded to Buy: Here's Why
Hyperfine, Inc. (HYPR) Q2 2025 Earnings Call Transcript
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates
Hyperfine, Inc. Reports Second Quarter 2025 Financial Results
Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System
Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments
Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025
Hyperfine Swoop® AI-Powered Portable MRI System Demonstrates 100% Sensitivity for ARIA-E Detection in New Data Presented at the 2025 Alzheimer's Association International Conference